CORE--CENTRAL COORDINATING CORE

核心--中央协调核心

基本信息

  • 批准号:
    7458888
  • 负责人:
  • 金额:
    $ 32.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-01 至 2008-05-31
  • 项目状态:
    已结题

项目摘要

The Central Coordinating Core (CCC) coordinates clinical research, database management, and strategic-planning across the PPG. The CCC implements the overall prospective longitudinal design of the program project (PPG) across three clinical sites. The goal is to recruit and to follow a sample of 450 subjects: 200 normal controls and 250 subjects with variable degrees of cognitive impairment attributed to subcortical ischemic vascular dementia (SIVD) or Alzheimer disease (AD). For normal controls < 80 years, cognitive/functional status is assessed every 2 years and magnetic resonance imaging (MRI) is repeated every 4 years. For subjects and older controls > 80 years, cognitive /functional status is followed every year, and MRI is repeated every 2 years. The research projects depend upon the CCC for classifying subjects and for ensuring the quality of key cognitive / functional data. Although the Pathology Core ultimately determines the likelihood of CVD, AD, or mixed AD/CVD, the CCC is responsible for obtaining consent and for coordinating the autopsy program. The CCC manages data from all three Cores (Clinical, Imaging, and Pathology). Key clinical variables include demographics, onset and duration of dementia, activities of daily living, mental status scores, neuropsychological test scores, clinical dementia rating (CDR), clinical diagnosis, and subject categorization. Key imaging data include the number, location, and size of lacunes, the volume of cortical gray matter, white matter, white matter hyperintensities (WML), ventricular and sulcal cerebral spinal fluid, and the volume of the hippocampi. The key pathological data include the overall likelihood ofAD, SIVD, or mixed AD/SIVD, numbers, size, and location of lacunar infarcts, and the severity of neurofibrillary tangles, neuritic plaques, white matter demyelination, and microvascular disease. These data are utilized by all four of the research projects. PPG investigators work well together. In person meetings are held at least twice a year to review progress, set goals, and to plan strategy. Monthly teleconferences are conducted to check progress and maintain course. Electronic communication tools, especially e-mail, mitigate the geographic distances between campuses. Consultants and an external advisory group provide invaluable feedback and guidance. The PPG functions as a vital and cohesive whole.
中央协调核心(CCC)协调PPG的临床研究、数据库管理和战略规划。CCC在三个临床研究中心实施项目(PPG)的总体前瞻性纵向设计。目的是招募和跟踪450名受试者的样本:200名正常对照和250名不同程度的认知障碍归因于皮质下缺血性血管性痴呆(SIVD)或阿尔茨海默病(AD)。对于< 80岁的正常对照,每2年评估一次认知/功能状态,每4年重复一次磁共振成像(MRI)。对于受试者和> 80岁的老年对照,每年随访认知/功能状态,每2年重复MRI。研究项目依靠CCC对受试者进行分类,并确保关键认知/功能数据的质量。尽管病理学核心最终决定了CVD、AD或AD/CVD混合的可能性,但CCC负责获得 同意并协调尸检程序。CCC管理来自所有三个核心(临床、成像和病理学)的数据。关键的临床变量包括人口统计学、痴呆的发作和持续时间、日常生活活动、精神状态评分、神经心理学测试 评分、临床痴呆评级(CDR)、临床诊断和受试者分类。关键的影像学资料包括腔隙的数量、位置和大小,皮质灰质、白色物质、白色物质高信号(WML)的体积,脑室和脑沟的脑脊液,以及脑室的体积。关键的病理学数据包括AD、SIVD或AD/SIVD混合的总体可能性,腔隙性梗死的数量、大小和位置,以及神经纤维缠结、神经炎性斑块、白色物质脱髓鞘和微血管疾病的严重程度。所有四个研究项目都使用这些数据。PPG研究人员合作良好。每年至少举行两次面对面会议,审查进展情况,设定目标, 并制定战略。每月举行电话会议,以检查进展情况和维持课程。电子通信工具,特别是电子邮件,缩短了校园之间的地理距离。顾问和外部咨询小组提供了宝贵的反馈和指导。方案规划小组作为一个重要和有凝聚力的整体发挥作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HELENA Chang CHUI其他文献

HELENA Chang CHUI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HELENA Chang CHUI', 18)}}的其他基金

Asian Cohort for Alzheimer's Disease (ACAD)
亚洲阿尔茨海默病队列 (ACAD)
  • 批准号:
    10555689
  • 财政年份:
    2023
  • 资助金额:
    $ 32.64万
  • 项目类别:
Quantitative cerebral blood vessel imaging biomarkers for AD and VCID
AD 和 VCID 的定量脑血管成像生物标志物
  • 批准号:
    10214060
  • 财政年份:
    2021
  • 资助金额:
    $ 32.64万
  • 项目类别:
Quantitative cerebral blood vessel imaging biomarkers for AD and VCID
AD 和 VCID 的定量脑血管成像生物标志物
  • 批准号:
    10721210
  • 财政年份:
    2021
  • 资助金额:
    $ 32.64万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    9922627
  • 财政年份:
    2020
  • 资助金额:
    $ 32.64万
  • 项目类别:
Alzheimer Disease Research Center
阿尔茨海默病研究中心
  • 批准号:
    10245804
  • 财政年份:
    2020
  • 资助金额:
    $ 32.64万
  • 项目类别:
Alzheimer Disease Research Center
阿尔茨海默病研究中心
  • 批准号:
    10641135
  • 财政年份:
    2020
  • 资助金额:
    $ 32.64万
  • 项目类别:
Alzheimer Disease Research Center
阿尔茨海默病研究中心
  • 批准号:
    10641166
  • 财政年份:
    2020
  • 资助金额:
    $ 32.64万
  • 项目类别:
USC ADRC Diversity Supplement - Guzman
南加州大学 ADRC 多样性补充 - 古兹曼
  • 批准号:
    10457217
  • 财政年份:
    2020
  • 资助金额:
    $ 32.64万
  • 项目类别:
Alzheimer Disease Research Center
阿尔茨海默病研究中心
  • 批准号:
    10655662
  • 财政年份:
    2020
  • 资助金额:
    $ 32.64万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10655663
  • 财政年份:
    2020
  • 资助金额:
    $ 32.64万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 32.64万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 32.64万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 32.64万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 32.64万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 32.64万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 32.64万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 32.64万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 32.64万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 32.64万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 32.64万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了